Aquinox Pharmaceuticals Company Profile (NASDAQ:AQXP)

Analyst Ratings

Consensus Ratings for Aquinox Pharmaceuticals (NASDAQ:AQXP) (?)
Ratings Breakdown: 1 Hold Rating(s), 5 Buy Rating(s)
Consensus Rating:Buy (Score: 2.83)
Consensus Price Target: $20.33 (144.39% upside)

Analysts' Ratings History for Aquinox Pharmaceuticals (NASDAQ:AQXP)
Show:
DateFirmActionRatingPrice TargetActions
7/21/2016Canaccord GenuitySet Price TargetBuy$22.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/12/2016Needham & Company LLCInitiated CoverageBuy$25.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/16/2016Leerink SwannLower Price TargetOutperform$26.00 -> $21.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/15/2016Jefferies GroupReiterated RatingHold$19.00 -> $9.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/3/2015Cowen and CompanyReiterated RatingBuy$23.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/6/2015GuggenheimInitiated CoverageBuy$22.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/28/2014 forward)

Earnings

Earnings History for Aquinox Pharmaceuticals (NASDAQ:AQXP)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
8/4/2016        
5/10/2016Q1($0.35)($0.39)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/14/2016Q4($0.37)($0.26)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/10/2015Q315($0.45)($0.43)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/6/2015Q215($0.56)($0.44)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/12/2015Q115($0.83)($0.60)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/15/2015($0.57)($0.78)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/16/2015($0.76)($0.78)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/4/2014($0.29)($0.59)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/11/2014($0.27)($0.51)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Aquinox Pharmaceuticals (NASDAQ:AQXP)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20162($0.38)($0.31)($0.35)
Q2 20162($0.47)($0.42)($0.45)
Q3 20162($0.53)($0.45)($0.49)
Q4 20162($0.59)($0.49)($0.54)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Aquinox Pharmaceuticals (NASDAQ:AQXP)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Aquinox Pharmaceuticals (NASDAQ:AQXP)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
3/16/2016Bros. Advisors Lp BakerMajor ShareholderBuy471,667$7.99$3,768,619.33View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/15/2016Bros. Advisors Lp BakerMajor ShareholderBuy109,912$7.98$877,097.76View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/26/2016Bros. Advisors Lp BakerMajor ShareholderBuy140,786$10.80$1,520,488.80View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/20/2016Bros. Advisors Lp BakerMajor ShareholderBuy112,034$9.48$1,062,082.32View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/19/2016Bros. Advisors Lp BakerMajor ShareholderBuy78,045$9.11$710,989.95View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/15/2016Bros. Advisors Lp BakerMajor ShareholderBuy202,623$8.28$1,677,718.44View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/10/2015Bros. Advisors Lp BakerMajor ShareholderBuy2,480,032$15.50$38,440,496.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/24/2015David Chilton MitchellVPBuy3,575$17.81$63,670.75View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/12/2015Kamran AlamCFOSell29,079$18.67$542,904.93View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/12/2015Lloyd MackenzieVPSell35,887$18.67$670,010.29View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/17/2014& Johnson JohnsonMajor ShareholderSell8,100$7.62$61,722.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/12/2014& Johnson JohnsonMajor ShareholderSell5,000$7.51$37,550.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/10/2014& Johnson JohnsonMajor ShareholderSell8,300$7.72$64,076.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/9/2014& Johnson JohnsonMajor ShareholderSell5,000$7.73$38,650.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/8/2014& Johnson JohnsonMajor ShareholderSell2,000$7.69$15,380.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/5/2014& Johnson JohnsonMajor ShareholderSell15,900$7.76$123,384.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/1/2014& Johnson JohnsonMajor ShareholderSell1,200$7.54$9,048.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/26/2014& Johnson JohnsonMajor ShareholderSell2,000$7.75$15,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/24/2014& Johnson JohnsonMajor ShareholderSell9,500$8.14$77,330.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/12/2014Pfizer IncMajor ShareholderBuy272,727$11.00$2,999,997.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Aquinox Pharmaceuticals (NASDAQ:AQXP)
DateHeadline
07/23/16 02:31 PMAquinox Pharmaceuticals, Inc. (NASDAQ:AQXP): A Quick Review & Update - Press Telegraph
07/23/16 05:48 AMEquity Roundup: Stock Performance Focus on Aquinox Pharmaceuticals, Inc. (NASDAQ:AQXP) - Press Telegraph
07/22/16 07:33 PMInvestor Attention Turning to Shares of Aquinox Pharmaceuticals, Inc. (NASDAQ:AQXP) - Engelwood Daily
07/22/16 02:32 PMTrading Examination: Performance check on Aquinox Pharmaceuticals, Inc. (NASDAQ:AQXP) - TGP
07/21/16 02:31 PMAquinox Pharmaceuticals, Inc. (NASDAQ:AQXP): Share Synopsis and Trading Review - Press Telegraph
07/21/16 02:31 PMMarket Minute - Focus on Aquinox Pharmaceuticals, Inc. (NASDAQ:AQXP) Stock - TGP
07/21/16 02:31 PMAquinox Pharmaceuticals (AQXP): Strong Industry, Solid Earnings Estimate Revisions - Nasdaq
07/21/16 02:31 PMAquinox Pharmaceuticals, Inc. (AQXP) Current Analyst Ratings - Fiscal Standard
07/21/16 06:55 AMAquinox Pharmaceuticals (AQXP): Strong Industry, Solid Earnings Estimate Revisions -
07/20/16 10:01 PMAquinox Pharmaceuticals, Inc. (NASDAQ:AQXP): Sell-Side Ratings and Company Earnings Glance - Engelwood Daily
07/20/16 03:44 PMEquity Update - Focusing on Shares of Aquinox Pharmaceuticals, Inc. (NASDAQ:AQXP) - Engelwood Daily
07/20/16 03:44 PMSession Focus: Performance Watch on Shares of Aquinox Pharmaceuticals, Inc. (NASDAQ:AQXP) - TGP
07/19/16 02:33 PMAquinox Pharmaceuticals Incorporated (NASDAQ:AQXP) Shorted Shares Increased 30.94% After Market Selling - Consumer Eagle
07/19/16 02:33 PMAquinox Pharmaceuticals, Inc. (AQXP) Updated Price Targets - FTSE News
07/19/16 02:33 PMAquinox Pharmaceuticals, Inc. (NASDAQ:AQXP): Stock Insight and Session Performance Spotcheck - Press Telegraph
07/19/16 02:33 PMSession Focus - Highlighting Shares of: Aquinox Pharmaceuticals, Inc. (NASDAQ:AQXP) - TGP
07/18/16 02:36 PMTracking Trading Performance for: Aquinox Pharmaceuticals, Inc. (NASDAQ:AQXP) - TGP
07/17/16 02:29 PMAquinox Pharmaceuticals, Inc. (NASDAQ:AQXP) Check on Sentiment Score - Press Telegraph
07/17/16 02:29 PMTrading Focus on Shares of: Aquinox Pharmaceuticals, Inc. (NASDAQ:AQXP) - TGP
07/17/16 07:19 AMAquinox Pharmaceuticals, Inc. (AQXP) Broker Price Targets For The Coming Week - Fiscal Standard
07/16/16 02:33 PMAquinox Pharmaceuticals Incorporated (NASDAQ:AQXP) Shorts Decreased by 13.08% After Short Covering - Consumer Eagle
07/16/16 02:33 PMAquinox Pharmaceuticals, Inc. (NASDAQ:AQXP) Stock Rating View - Engelwood Daily
07/15/16 01:07 PMStock Trading Action Review for: Aquinox Pharmaceuticals, Inc. (NASDAQ:AQXP) - Telanagana Press
07/15/16 01:07 PMAquinox Pharmaceuticals Inc Can't Be More Risky. The Stock Formed a Wedge Down - Consumer Eagle
07/15/16 01:07 PMNew Broker Ratings For Aquinox Pharmaceuticals, Inc. (AQXP) - FTSE News
07/14/16 02:34 PMAnalysts are Watching Shares of: Aquinox Pharmaceuticals, Inc. (NASDAQ:AQXP) - Telanagana Press
07/14/16 02:34 PMEquity Insight on Aquinox Pharmaceuticals, Inc. (NASDAQ:AQXP) Shares - Telanagana Press
07/13/16 08:01 PMAquinox Pharmaceuticals, Inc. (NASDAQ:AQXP) - Focus Stock Review - Engelwood Daily
07/13/16 10:37 AMStock Performance Summary on Shares of: Aquinox Pharmaceuticals, Inc. (NASDAQ:AQXP) - Telanagana Press
07/13/16 10:37 AMAquinox Pharmaceuticals, Inc. (NASDAQ:AQXP) Earnings Concentration and Analyst Target Watch - Engelwood Daily
07/13/16 10:37 AMCompany Sentiment Score Update:Aquinox Pharmaceuticals, Inc. (NASDAQ:AQXP) - Press Telegraph
07/12/16 02:36 PMConsensus Target and Stock Rating Report: Aquinox Pharmaceuticals, Inc. (NASDAQ:AQXP) - Telanagana Press
07/12/16 02:36 PMEquity Review - Shares in Focus: Aquinox Pharmaceuticals, Inc. (NASDAQ:AQXP) - Telanagana Press
07/12/16 02:36 PMAnalyst Target and Average Rating Watch: Aquinox Pharmaceuticals, Inc. (NASDAQ:AQXP) - Press Telegraph
07/12/16 02:36 PMTarget Tracker and Earnings View for Aquinox Pharmaceuticals, Inc. (NASDAQ:AQXP) - Press Telegraph
07/12/16 02:36 PMAquinox Pharmaceuticals, Inc. (NASDAQ:AQXP): Recent Share Performance Watch - Press Telegraph
07/11/16 07:36 PMImpact Score and Stock Sentiment Outlook :Aquinox Pharmaceuticals, Inc. (NASDAQ:AQXP) - Press Telegraph
07/11/16 02:32 PMTrading Review - Company in Focus: Aquinox Pharmaceuticals, Inc. (NASDAQ:AQXP) - Telanagana Press
07/11/16 02:32 PMAquinox Pharmaceuticals, Inc. (NASDAQ:AQXP) Earnings Recap and Sell-side Recommendation Review - Telanagana Press
07/10/16 02:30 PMAquinox Pharmaceuticals, Inc. (NASDAQ:AQXP): Check on Company Stock Performance - Press Telegraph
07/08/16 02:34 PMAquinox Pharmaceuticals, Inc. (NASDAQ:AQXP) Wall Street Rating Watch and Earnings Glance - Telanagana Press
07/08/16 02:34 PMAquinox Pharmaceuticals Inc. Stock Momentum at Critical Inflection Point - CML News
07/08/16 02:34 PMNews Sentiment and Impact Score Review for :Aquinox Pharmaceuticals, Inc. (NASDAQ:AQXP) - Press Telegraph
07/07/16 02:33 PMEarnings Review and Price Target Watch for Aquinox Pharmaceuticals, Inc. (NASDAQ:AQXP) - Press Telegraph
07/06/16 08:20 PMAquinox Pharmaceuticals, Inc. (NASDAQ:AQXP) Earnings Check and Analyst Rating Update - Telanagana Press
07/06/16 08:20 PMAquinox Pharmaceuticals, Inc. (NASDAQ:AQXP) Share Review and Target Focus - Engelwood Daily
07/06/16 02:36 PMCurrent Stock Trading Roundup for: Aquinox Pharmaceuticals, Inc. (NASDAQ:AQXP) - Telanagana Press
07/06/16 02:36 PMCan Aquinox Pharmaceuticals, Inc. (NASDAQ:AQXP) Improve on the Earnings Front? - Engelwood Daily
06/06/16 01:32 PMAquinox Pharmaceuticals, Inc. :AQXP-US: Earnings Analysis: Q1, 2016 By the Numbers : June 6, 2016 -
06/01/16 08:15 AMAquinox to Present at Jefferies 2016 Healthcare Conference - [GlobeNewswire] - VANCOUVER, British Columbia, June 01, 2016-- Aquinox Pharmaceuticals, Inc., a clinical-stage pharmaceutical company discovering and developing targeted therapeutics in disease areas of inflammation and ...

Social

About Aquinox Pharmaceuticals

Aquinox Pharmaceuticals logoAquinox Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company discovering and developing targeted therapeutics in disease areas of inflammation and immuno-oncology. The Company operates in the segment of identification and development of therapeutics in disease areas of inflammation and immuno-oncology. Its primary focus is anti-inflammatory product candidates targeting the Src Homology 2 (SH2)-containing inositol-5-phosphatase 1 (SHIP1) enzyme, which is a regulator of a cellular signaling pathway in immune cells. The Company's product candidate, AQX-1125, is a small molecule activator of SHIP1 suitable for oral, once daily dosing. The Company is developing AQX-1125 as a treatment in interstitial cystitis/bladder pain syndrome (IC/BPS), a chronic inflammatory disease of the bladder. It has completed and reported results from its Leadership trial, which is a multicenter, randomized, double-blind, placebo-controlled, Phase II clinical trial.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Drugs - Generic
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: AQXP
  • CUSIP:
Key Metrics:
  • Previous Close: $8.32
  • 50 Day Moving Average: $7.14
  • 200 Day Moving Average: $8.55
  • P/E Ratio: N/A
  • P/E Growth: 0.00
  • Market Cap: $143.20M
  • Beta: -19.56
  • Current Year EPS Consensus Estimate: $-1.79 EPS
  • Next Year EPS Consensus Estimate: $-1.91 EPS
Additional Links:
Aquinox Pharmaceuticals (NASDAQ:AQXP) Chart for Thursday, July, 28, 2016